구강암의 연구동향 및 임상적 의의

다국어 초록 (Multilingual Abstract)

Recent advancement in molocular biology enhanced further understanding of the carcinogenesis of oral cancer and its relation with various genetic backgrounds. Familial risk factors includes similar habits of the family and polymorphic variations of the genes. Recently, human papilloma virus has been suggested to be linked with oral cancer progression. Enhancement of understanding of the damage or alteration in molecular pathway in various cellular response of oral cancer progression would lead the targeted therapy or precise early diagnosis of the oral cancer.

목차 (Table of Contents)

• ABSTRACT
• Ⅰ. 서론
• Ⅱ. 구강암과 관련된 분자 생물학적 변이(Molecular / Genetic alterations in oral cancer)
• Ⅲ. 바이러스와 구강암
• Ⅴ. 결론
• 참고문헌

참고문헌 (Reference)

1 Shin DM, "p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma" 88 : 519-529, 1996

2 Chang X, "dentification of hypermethylated genes associated with cisplatin resistance in human cancers" 1 (1): 2870-2879, 2010

3 Rosin MP, "Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia" 6 : 357-, 2000

4 Folkman J, "Tumor angiogenesis: therapeutic implications" 18 (18): 1182-1186, 1971

5 Field JK, "The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck" 119 : 1118-1122, 1993

6 Xie X, "The prognostic value of spontaneous apoptosis. Bax, Bcl- 2, and p53 in oral squamous cell carcinoma of the tongue" 86 : 913-920, 1999

7 Partridge M, "The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer" 79 : 1821-1827, 1999

8 Strome SE, "Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations" 8 : 1093-1100, 2002

9 Liggett Jr WH, "Role of the p16 tumor suppressor gene in cancer" 16 : 1197-1206, 1998

10 Copper MP, "Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck" 121 : 157-160, 1995

11 Bonner JA, "Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck" 354 : 567-578, 2006

12 Esteller M, "Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors" 5 (5): 564-569, 2000

13 Bettendorf O, "Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?" 40 : 110-119, 2004

14 Callender T, "PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma" 74 : 152-158, 1994

15 Mehanna H, "Oropharyngeal carcinoma related to human papillomavirus" 25 (25): 1439-, 2010

16 Nagpal JK, "Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management" 39 : 213-221, 2003

17 Patel V, "New approaches to the understanding of the molecular basis of oral cancer" 12 : 55-63, 2001

18 "National Cancer Institute, Study Estimates Overall HPV Prevalence in U.S. Women"

19 Nigro JM, "Mutations in the p53 gene occur in diverse human tumour types" 342 : 705-708, 1989

20 Le Tourneau C, "Molecular targeted therapy of head and neck cancer: review and clinical development challenges" 43 : 2457-2466, 2007

21 Pai SI, "Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment" 4 : 49-70, 2009

22 Williams HK, "Molecular pathogenesis of oral squamous carcinoma" 53 : 165-172, 2000

23 Figueiredo ML, "Molecular mechanisms of head and neck cancer" 1 : 273-281, 2004

24 Gleich LL, "Molecular genetics of head and neck cancer" 9 : 369-378, 2002

25 Brennan JA, "Molecular assessment of histopathological staging in squamouscell carcinoma of the head and neck" 332 : 429-435, 1995

26 Rubin Grandis J, "Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival" 90 : 824-832, 1998

27 Bockmuhl U, "Improved prognostic assessment of head-neck carcinomas by new genetic markers" 48 : 451-456, 2000

28 McDonald JS, "Immunhistochemical detection of the Hras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck" 23 : 342-346, 1994

29 Mellin H, "Humanpapillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival" 89 : 300-304, 2000

30 Sisk EA, "Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma" 24 : 841-849, 2002

31 Bockmuhl U, "Genomic alterations associated with malignancy in head and neck cancer" 20 : 145-151, 1998

32 Scully C, "Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations" 36 : 311-327, 2000

33 Califano J, "Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization" 56 : 2488-2492, 1996

34 Herman JG, "Gene silencing in cancer in association with promoter hypermethylation" 349 : 2042-2054, 2003

35 Sanchez-Cespedes M, "Gene promoter hypermethylation in tumors and serum of head and neck cancer patients" 15 : 892-895, 2000

36 Ishitoya J, "Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck" 59 : 559-562, 1989

37 Slaughter DP, "Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin" 6 : 963-968, 1953

38 Foulkes WD, "Familial risks of squamous cell carcinoma of thehead and neck: a retrospective case-control study" 313 : 716-720, 1996

39 Parkin DM, "Estimates of the worldwide frequency of sixteen major cancers in 1980" 41 : 184-189, 1988

40 Cripps C, "Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer" 17 : 37-48, 2010

41 Bentzen SM, "Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial" 23 : 5560-5567, 2005

42 Dobosy JR, "Emerging connections between DNA methylation and histone acetylation" 58 : 721-727, 2001

43 Nobori T, "Deletions of the cyclin-dependent kinase- 4 inhibitor gene in multiple human cancers" 368 : 753-756, 1994

44 Kyomoto R, "Cyclin D1 gene amplification is a more potent prognostic factor than its protein overexpression in human head and neck squamous cell carcinoma" 74 : 576-581, 1997

45 Gillespie MB, "Curr Treat Options Oncol" 10 : 296-307, 2009

46 Williams ME, "Chromosome 11Q13 amplification in head and neck squamous cell carcinoma" 119 : 1238-1243, 1993

47 D’Souza G, "Casecontrol study of human papillomavirus and oropharyngeal cancer" 356 : 1944-1956, 2007

48 Werness BA, "Association of human papillomavirus types 16 and 18 E6 proteins with p53" 248 : 76-79, 1990

49 Glazer CA, "Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice" 45 : 440-446, 2009

50 Xu J, "Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use" 83 : 204-212, 1998

51 Cruz IB, "Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas" 32 : 55-62, 1996

52 Serrano M, "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4" 366 : 704-707, 1993

53 Khuri FR, "A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer" 6 : 879-885, 2000

54 Bockmuhl U, "8. Bockmuhl U, Schwendel A, Dietel M, Petersen I. Distinct patterns of chromosomal alterations in highand low-grade head and neck squamous cell carcinomas" 56 : 5325-5329, 1996